These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36934021)
1. Contribution of nuclear medicine to the diagnosis and management of primary brain tumours. Horowitz T; Tabouret E; Graillon T; Salgues B; Chinot O; Verger A; Guedj E Rev Neurol (Paris); 2023 Jun; 179(5):394-404. PubMed ID: 36934021 [TBL] [Abstract][Full Text] [Related]
2. Differentiation between malignant transformation and tumour recurrence by (68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomas. Seiz M; Dimitrakopoulou-Strauss A; Schubert GA; Weinmann C; Strauss LG; Eisenhut M; Tuettenberg J Hell J Nucl Med; 2008; 11(3):149-52. PubMed ID: 19081856 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis. Sasikumar A; Joy A; Pillai MR; Nanabala R; Anees K M; Jayaprakash PG; Madhavan J; Nair S Clin Nucl Med; 2017 Jan; 42(1):e41-e48. PubMed ID: 27846000 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Chung JK; Kim YK; Kim SK; Lee YJ; Paek S; Yeo JS; Jeong JM; Lee DS; Jung HW; Lee MC Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):176-82. PubMed ID: 11926379 [TBL] [Abstract][Full Text] [Related]
5. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas]. Galldiks N; Langen KJ Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228 [TBL] [Abstract][Full Text] [Related]
6. Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors. Borja AJ; Saini J; Raynor WY; Ayubcha C; Werner TJ; Alavi A; Revheim ME; Nagaraj C PET Clin; 2022 Jul; 17(3):431-451. PubMed ID: 35662494 [TBL] [Abstract][Full Text] [Related]
7. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis. Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence. Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642 [TBL] [Abstract][Full Text] [Related]
9. (18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes. Wray R; Solnes L; Mena E; Meoded A; Subramaniam RM PET Clin; 2015 Jul; 10(3):423-30. PubMed ID: 26099676 [TBL] [Abstract][Full Text] [Related]
10. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329 [TBL] [Abstract][Full Text] [Related]
11. Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma. Li D; Zhang J; Ji N; Zhao X; Zheng K; Qiao Z; Li F; Lang L; Iagaru A; Niu G; Zhu Z; Chen X Clin Nucl Med; 2018 Sep; 43(9):648-654. PubMed ID: 30052597 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348 [TBL] [Abstract][Full Text] [Related]
13. Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma. Pöpperl G; Götz C; Rachinger W; Gildehaus FJ; Tonn JC; Tatsch K Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1464-70. PubMed ID: 15248032 [TBL] [Abstract][Full Text] [Related]
14. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI. Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531 [TBL] [Abstract][Full Text] [Related]
15. The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms. Montes A; Fernández A; Camacho V; de Quintana C; Gallego O; Craven-Bartle J; López D; Molet J; Gómez-Ansón B; Carrió I Rev Esp Med Nucl Imagen Mol; 2017; 36(4):227-232. PubMed ID: 28219644 [TBL] [Abstract][Full Text] [Related]
16. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205 [TBL] [Abstract][Full Text] [Related]
17. Combined PET/MRI in brain glioma imaging. Almansory KO; Fraioli F Br J Hosp Med (Lond); 2019 Jul; 80(7):380-386. PubMed ID: 31283392 [TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography for radiation treatment planning. Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216 [TBL] [Abstract][Full Text] [Related]